1. Home
  2. LGND vs FA Comparison

LGND vs FA Comparison

Compare LGND & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • FA
  • Stock Information
  • Founded
  • LGND 1987
  • FA 2003
  • Country
  • LGND United States
  • FA United States
  • Employees
  • LGND N/A
  • FA N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • FA Business Services
  • Sector
  • LGND Health Care
  • FA Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • FA Nasdaq
  • Market Cap
  • LGND 2.0B
  • FA 2.4B
  • IPO Year
  • LGND 1992
  • FA 2021
  • Fundamental
  • Price
  • LGND $102.19
  • FA $17.12
  • Analyst Decision
  • LGND Strong Buy
  • FA Hold
  • Analyst Count
  • LGND 8
  • FA 6
  • Target Price
  • LGND $144.71
  • FA $20.75
  • AVG Volume (30 Days)
  • LGND 118.3K
  • FA 1.2M
  • Earning Date
  • LGND 05-08-2025
  • FA 05-08-2025
  • Dividend Yield
  • LGND N/A
  • FA N/A
  • EPS Growth
  • LGND N/A
  • FA N/A
  • EPS
  • LGND N/A
  • FA N/A
  • Revenue
  • LGND $181,488,000.00
  • FA $1,045,377,000.00
  • Revenue This Year
  • LGND $17.68
  • FA $82.75
  • Revenue Next Year
  • LGND $18.69
  • FA $6.42
  • P/E Ratio
  • LGND N/A
  • FA N/A
  • Revenue Growth
  • LGND 53.40
  • FA 37.98
  • 52 Week Low
  • LGND $77.43
  • FA $12.32
  • 52 Week High
  • LGND $129.90
  • FA $20.79
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • FA 55.90
  • Support Level
  • LGND $98.90
  • FA $16.86
  • Resistance Level
  • LGND $103.17
  • FA $17.57
  • Average True Range (ATR)
  • LGND 3.05
  • FA 0.58
  • MACD
  • LGND -0.27
  • FA -0.16
  • Stochastic Oscillator
  • LGND 31.94
  • FA 15.19

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About FA First Advantage Corporation

First Advantage Corp is a provider of employment background screening and verification solutions. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment, which performs various background checks and compliance services across all phases of the workforce lifecycle, from pre-onboarding services to post-onboarding and ongoing monitoring services, covering employees, contractors, contingent workers, tenants, and drivers. The company delivers solutions across multiple industry verticals in the United States, Canada, and Latin America. Geographically, it derives key revenue from the United States.

Share on Social Networks: